HomeTCGGY • OTCMKTS
add
Tecan Group ADR
Previous close
$83.50
Year range
$69.50 - $83.50
Market cap
2.75B CHF
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 233.58M | -13.73% |
Operating expense | 67.44M | -4.70% |
Net income | 11.23M | -57.78% |
Net profit margin | 4.81 | -51.02% |
Earnings per share | — | — |
EBITDA | 26.46M | -40.50% |
Effective tax rate | 20.45% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 343.78M | 10.13% |
Total assets | 2.12B | 1.85% |
Total liabilities | 710.17M | -3.35% |
Total equity | 1.41B | — |
Shares outstanding | 12.79M | — |
Price to book | 0.76 | — |
Return on assets | 1.53% | — |
Return on capital | 1.89% | — |
Cash Flow
Net change in cash
| (CHF) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 11.23M | -57.78% |
Cash from operations | 21.71M | -47.34% |
Cash from investing | -6.50M | 51.81% |
Cash from financing | -28.90M | -34.24% |
Net change in cash | -12.34M | -332.26% |
Free cash flow | 23.38M | -27.14% |
About
Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and medical technology for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics.
The company specializes in laboratory automation. As an original equipment manufacturer, it develops and manufactures OEM instruments, components and medical devices that are then distributed by partner companies.
Founded in Switzerland, in 1980, the company has over 3,500 employees, owns production and research and development sites in both North America, Europe and APAC and maintains a sales and service network in 52 countries.
In 2021, Tecan generated sales of CHF 946 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange. Wikipedia
Founded
1980
Headquarters
Website
Employees
3,000
